The Royal Pharmaceutical Society, British Medical Association and Royal College of General Practitioners have published joint statements calling for greater use of community and 'clinical' pharmacists across primary care networks (PCNs).
The statements highlight pharmacists’ expertise in medicines and how they can achieve better outcomes for patients as part of the multidisciplinary team.
Chair of the RPS in England, Claire Anderson, said: “There is a huge opportunity for pharmacists to support better outcomes for patients and improve medicines safety across primary care networks. Making the most of this potential will need local GP and pharmacy leaders to work together, so it is great to see this recognised in these joint statements.”
The statement on community pharmacists encourages all PCN clinical directors to consider how they can be partners in supporting the health and wellbeing of the local population, including helping to address current workload pressures.
The statement calls for:
Dr Krishna Kasaraneni, BMA GP committee executive team member, said: “For primary care networks to thrive, offer the best to patients and address workload pressures, it is crucial that all health professionals are able to form strong partnerships across the local area.
“Community and clinical pharmacists are valued colleagues, who have an important role to play in networks, and we look forward to working with the RPS, RCGP and NHS to explore how we can support one another in developing these opportunities.”